P2RY12 and ischemic stroke: Finally, we show that P2ry12-CreER can be used to label microglia in middle cerebral artery occlusion (MCAO)-induced ischemic stroke, as well as experimental autoimmune encephalomyelitis (EAE), a model of multiple sclerosis.